Skip to main content
Top
Published in: Surgery Today 6/2015

01-06-2015 | Original Article

Protein kinase Cι is a new prognostic factor in gastric cancer

Authors: Hideya Kashihara, Mitsuo Shimada, Nobuhiro Kurita, Takashi Iwata, Hirohiko Sato, Kozo Yoshikawa, Tomohiko Miyatani, Chie Takasu, Noriko Matsumoto

Published in: Surgery Today | Issue 6/2015

Login to get access

Abstract

Purposes

Protein kinase Cι (PKCι) is an important oncogenic K-ras effector, and its expression is correlated with tumor angiogenesis. The role of PKCι in gastric cancer remains unclear. The aim of this study was to clarify the role of PKCι in gastric cancer.

Methods

Twenty-eight patients with gastric cancer who underwent gastrectomy were enrolled in this study. The expression of PKCι mRNA was determined, as were the clinicopathological factors. The patients were divided into PKCι high and low expression groups. The 5-year survival rate, ERK mRNA level and VEGF mRNA level were compared between the two groups. The prognostic factors were investigated by a multivariate analysis.

Results

High expression of PKCι was observed to be associated with a lack of differentiation, tumor invasion ≥muscularis propria≤, stage III and IV disease and peritoneal dissemination. The 5-year survival rate in the PKCι high group was lower than that in the PKCι low group. The multivariate analysis revealed that a high expression level of PKCι was an independent prognostic factor. The expression levels of ERK and VEGF in the PKCι high group were higher than those in the PKCι low group.

Conclusion

Our results indicate that PKCι is correlated with tumor progression and angiogenesis. PKCι may be a new prognostic factor for gastric cancer.
Literature
2.
go back to reference Cancer (Fact sheet N°297) (2009) World Health Organization. Cancer (Fact sheet N°297) (2009) World Health Organization.
3.
go back to reference Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.CrossRefPubMed Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–32.CrossRefPubMed
4.
go back to reference Soh K, Yanagisawa A, Hiratsuka H, Sugano H, Kato Y. Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors. Jpn J Cancer Res. 1993;84:388–93.CrossRefPubMed Soh K, Yanagisawa A, Hiratsuka H, Sugano H, Kato Y. Variation in K-ras codon 12 point mutation rate with histological atypia within individual colorectal tumors. Jpn J Cancer Res. 1993;84:388–93.CrossRefPubMed
5.
go back to reference Cooper GM. Guanine nucleotide binding proteins. In: Cooper GM, editor. Oncogenes. 2nd ed. Sudbury: Jones and Bartlett; 1995. p. 222–42. Cooper GM. Guanine nucleotide binding proteins. In: Cooper GM, editor. Oncogenes. 2nd ed. Sudbury: Jones and Bartlett; 1995. p. 222–42.
6.
go back to reference Tahara E. Molecular mechanism of stomach carcinogenesis. Cancer Res Clin Oncol. 1993;119:265–72.CrossRef Tahara E. Molecular mechanism of stomach carcinogenesis. Cancer Res Clin Oncol. 1993;119:265–72.CrossRef
7.
go back to reference Arber N, Shapira I, Ratan J, Stern B, Hibshoosh H, Moshkowitz M, et al. Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology. 2000;118:1045–50.CrossRefPubMed Arber N, Shapira I, Ratan J, Stern B, Hibshoosh H, Moshkowitz M, et al. Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology. 2000;118:1045–50.CrossRefPubMed
8.
go back to reference Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, Tanaka S, et al. K-ras mutation in Helicobacter pylori associated chronic gastritis in patients with and without gastric cancer. Int J Cancer. 2002;97:562–6.CrossRefPubMed Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, Tanaka S, et al. K-ras mutation in Helicobacter pylori associated chronic gastritis in patients with and without gastric cancer. Int J Cancer. 2002;97:562–6.CrossRefPubMed
9.
go back to reference Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol. 2000;279:L429–38.PubMed Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol. 2000;279:L429–38.PubMed
12.
go back to reference Poole AW, Pula G, Hers I, Crosby D, Jones ML. PKC-interacting proteins from function to pharmacology. Trends Pharmacol Sci. 2004;25:528–35.CrossRefPubMed Poole AW, Pula G, Hers I, Crosby D, Jones ML. PKC-interacting proteins from function to pharmacology. Trends Pharmacol Sci. 2004;25:528–35.CrossRefPubMed
14.
go back to reference Murray NR, Jamieson L, Yu W, Zhang J, Gökmen-Polar Y, Sier D, et al. Protein kinase Cɩ is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol. 2004;164:797–802.CrossRefPubMedCentralPubMed Murray NR, Jamieson L, Yu W, Zhang J, Gökmen-Polar Y, Sier D, et al. Protein kinase Cɩ is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol. 2004;164:797–802.CrossRefPubMedCentralPubMed
15.
go back to reference Regala RP, Davis RK, Kunz A, Khoor A, Leitges M, Fields AP. Atypical protein kinase Cɩ is required for bronchoalveolar stem cell expansion and lung tumorigenesis. Cancer Res. 2009;69(19):7603–11.CrossRefPubMedCentralPubMed Regala RP, Davis RK, Kunz A, Khoor A, Leitges M, Fields AP. Atypical protein kinase Cɩ is required for bronchoalveolar stem cell expansion and lung tumorigenesis. Cancer Res. 2009;69(19):7603–11.CrossRefPubMedCentralPubMed
16.
go back to reference Scotti ML, Bamlet WR, Smyrk TC, Fields AP, Murray NR. Protein kinase Cɩ is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res. 2010;70(5):2064–74.CrossRefPubMedCentralPubMed Scotti ML, Bamlet WR, Smyrk TC, Fields AP, Murray NR. Protein kinase Cɩ is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res. 2010;70(5):2064–74.CrossRefPubMedCentralPubMed
17.
go back to reference Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 14th ed. Tokyo: Kanehara; 2010. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma. 14th ed. Tokyo: Kanehara; 2010.
18.
go back to reference Zhang J, Anastasiadis PZ, Liu Y, Thompson EA, Fields AP. Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKCɩ/Rac 1-dependent signaling pathway. J Biol Chem. 2004;279:22118–23.CrossRefPubMed Zhang J, Anastasiadis PZ, Liu Y, Thompson EA, Fields AP. Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKCɩ/Rac 1-dependent signaling pathway. J Biol Chem. 2004;279:22118–23.CrossRefPubMed
19.
go back to reference Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science. 1998;281:2042–5.CrossRefPubMed Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science. 1998;281:2042–5.CrossRefPubMed
20.
go back to reference Moscat J, Diaz-Meco MT. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep. 2001;1:399–403.CrossRef Moscat J, Diaz-Meco MT. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep. 2001;1:399–403.CrossRef
21.
go back to reference Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP, et al. Atypical PKCɩ contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci USA. 2005;102:12519–24.CrossRefPubMedCentralPubMed Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP, et al. Atypical PKCɩ contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci USA. 2005;102:12519–24.CrossRefPubMedCentralPubMed
22.
go back to reference Regala RP, Weems C, Jamieson L, Khoor A, Edell ES, Lohse CM, et al. Atypical protein kinase C iota is an oncogene in human non small cell lung cancer. Cancer Res. 2005;65:8905–11.CrossRefPubMed Regala RP, Weems C, Jamieson L, Khoor A, Edell ES, Lohse CM, et al. Atypical protein kinase C iota is an oncogene in human non small cell lung cancer. Cancer Res. 2005;65:8905–11.CrossRefPubMed
23.
go back to reference Zhang L, Huang J, Yang N, Liang S, Barchetti A, Giannakakis A, et al. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCɩ as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res. 2006;66:4627–35.CrossRefPubMed Zhang L, Huang J, Yang N, Liang S, Barchetti A, Giannakakis A, et al. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCɩ as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res. 2006;66:4627–35.CrossRefPubMed
24.
go back to reference Yang YL, Chu JY, Luo ML, Wu YP, Zhang Y, Feng YB, et al. Amplification of PRKCι, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosom Cancer. 2008;47:127–36.CrossRefPubMed Yang YL, Chu JY, Luo ML, Wu YP, Zhang Y, Feng YB, et al. Amplification of PRKCι, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosom Cancer. 2008;47:127–36.CrossRefPubMed
25.
go back to reference Liu SG, Wang BS, Jiang YY, Zhang TT, Shi ZZ, Yang Y, et al. A typical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway. Mol Cancer Res. 2011;9(4):390–402.CrossRefPubMed Liu SG, Wang BS, Jiang YY, Zhang TT, Shi ZZ, Yang Y, et al. A typical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway. Mol Cancer Res. 2011;9(4):390–402.CrossRefPubMed
26.
go back to reference van Grieken NCT, Aoyma T, Chambers PA, et al. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicenter study. Br J Cancer. 2013;108:1495–501.CrossRefPubMedCentralPubMed van Grieken NCT, Aoyma T, Chambers PA, et al. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicenter study. Br J Cancer. 2013;108:1495–501.CrossRefPubMedCentralPubMed
27.
go back to reference Pearson G, Robinson F, Beers Gibson T et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001; 22(2): 153–83. Pearson G, Robinson F, Beers Gibson T et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001; 22(2): 153–83.
28.
go back to reference Atmaca A, Pauligk C, Steinmetz K, Altmannsberger HM, Jäger E, Al-Batran SE. Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer. Oncology. 2011;80(1–2):130–4.CrossRefPubMed Atmaca A, Pauligk C, Steinmetz K, Altmannsberger HM, Jäger E, Al-Batran SE. Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer. Oncology. 2011;80(1–2):130–4.CrossRefPubMed
29.
go back to reference Billadeau DD, Chatterjee S, Bramati P, Sreekumar R, Shah V, Hedin K, et al. Characterization of the CXCR4 signaling in pancreatic cancer cells. Int J Gastrointest Cancer. 2006;37:110–9.PubMed Billadeau DD, Chatterjee S, Bramati P, Sreekumar R, Shah V, Hedin K, et al. Characterization of the CXCR4 signaling in pancreatic cancer cells. Int J Gastrointest Cancer. 2006;37:110–9.PubMed
Metadata
Title
Protein kinase Cι is a new prognostic factor in gastric cancer
Authors
Hideya Kashihara
Mitsuo Shimada
Nobuhiro Kurita
Takashi Iwata
Hirohiko Sato
Kozo Yoshikawa
Tomohiko Miyatani
Chie Takasu
Noriko Matsumoto
Publication date
01-06-2015
Publisher
Springer Japan
Published in
Surgery Today / Issue 6/2015
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-014-1010-5

Other articles of this Issue 6/2015

Surgery Today 6/2015 Go to the issue